A Cluster Sequencing Strategy To Determine the Consensus Affinity Domains in Heparin for Its Binding to Specific Proteins

Anal Chem. 2022 Oct 11;94(40):13987-13994. doi: 10.1021/acs.analchem.2c03267. Epub 2022 Oct 2.

Abstract

Glycosaminoglycans (GAGs) have high negative charge and are biologically and pharmaceutically important because their high charge promotes a strong interaction with many proteins. Due to the inherent heterogeneity of GAGs, multiple oligosaccharides, containing certain common domains, often can interact with clusters of basic amino acid residues on a target protein. The specificity of many GAG-protein interactions remains undiscovered since there is insufficient structural information on the interacting GAGs. Herein, we establish a cluster sequencing strategy to simultaneously deduce all major sequences of the affinity GAG oligosaccharides, leading to a definition of the consensus sequence they share that corresponds to the specific binding domain for the target protein. As a proof of concept, antithrombin III-binding oligosaccharides were examined, resulting in a heptasaccharide domain containing the well-established anticoagulant pentasaccharide sequence. Repeating this approach, a new pentasaccharide domain was discovered corresponding to the heparin motif responsible for binding interferon-γ (IFNγ). Our strategy is fundamentally important for the discovery of saccharide sequences needed in the development of novel GAG-based therapeutics.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids, Basic / metabolism
  • Anticoagulants
  • Antithrombin III* / chemistry
  • Antithrombin III* / metabolism
  • Glycosaminoglycans / chemistry
  • Heparin* / chemistry
  • Interferon-gamma
  • Oligosaccharides / chemistry
  • Protein Binding

Substances

  • Amino Acids, Basic
  • Anticoagulants
  • Glycosaminoglycans
  • Oligosaccharides
  • Interferon-gamma
  • Antithrombin III
  • Heparin